Tag Archives: FDA Authorization

Formulated at UNC, Remdesivir Earns FDA Authorization

On Thursday, the U.S. Nutrition and Drug Administration authorized the antiviral drug Veklury (remdesivir) in grown-up and pediatric victims for the therapy of COVID-19. Remdesivir is the early therapy for COVID-19 to earn FDA permission. To earn the therapy victims must be 12 years of duration and former and evaluating …

Read More »